BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28587731)

  • 21. Mentored experience of establishing a national peritoneal malignancy programme - Experience of first 50 operative cases.
    Chang KH; Kazanowski M; Staunton O; Cahill RA; Moran BJ; Shields C; Mulsow J
    Eur J Surg Oncol; 2017 Feb; 43(2):395-400. PubMed ID: 27955836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.
    Andréasson H; Graf W; Nygren P; Glimelius B; Mahteme H
    Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.
    Wheeler BR; Reddy SK; Kenwright D; Keating JP
    N Z Med J; 2014 Feb; 127(1389):31-9. PubMed ID: 24548955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit.
    Shiralkar SP; Kerr P; Scott J; Sivalingam P
    Anaesth Intensive Care; 2017 Jul; 45(4):490-498. PubMed ID: 28673220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score.
    Bouquot M; Dohan A; Gayat E; Barat M; Glehen O; Pocard M; Rousset P; Eveno C
    Ann Surg Oncol; 2018 Mar; 25(3):694-701. PubMed ID: 29192372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative Surgery for Pseudomyxoma Peritonei.
    Funder JA; Jepsen KV; Stribolt K; Iversen LH
    Scand J Surg; 2016 Jun; 105(2):84-9. PubMed ID: 26232048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
    Ann Surg Oncol; 2019 Jan; 26(1):238-243. PubMed ID: 30421066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin.
    Tan GH; Novo CA; Dayal S; Chandrakumaran K; Mohamed F; Cecil T; Moran BJ
    Eur J Surg Oncol; 2017 Feb; 43(2):388-394. PubMed ID: 27866811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Güner Z; Schmidt U; Dahlke MH; Schlitt HJ; Klempnauer J; Piso P
    Int J Colorectal Dis; 2005 Mar; 20(2):155-60. PubMed ID: 15503065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery?
    Liu Y; Mizumoto A; Ishibashi H; Takeshita K; Hirano M; Ichinose M; Takegawa S; Yonemura Y
    Eur J Surg Oncol; 2016 Jul; 42(7):1018-23. PubMed ID: 27241925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Horvath P; Yurttas C; Birk P; Struller F; Königsrainer A
    Langenbecks Arch Surg; 2018 Dec; 403(8):985-990. PubMed ID: 30506401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Canbay E; Ishibashi H; Sako S; Mizumoto A; Hirano M; Ichinose M; Takao N; Yonemura Y
    World J Surg; 2013 Jun; 37(6):1271-6. PubMed ID: 23467926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours.
    Ansari N; Chandrakumaran K; Dayal S; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2016 Jul; 42(7):1035-41. PubMed ID: 27132072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
    Dayal S; Taflampas P; Riss S; Chandrakumaran K; Cecil TD; Mohamed F; Moran BJ
    Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
    Järvinen P; Ristimäki A; Kantonen J; Lepistö A
    Scand J Surg; 2013; 102(3):145-51. PubMed ID: 23963027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term outcomes following cytoreductive surgery and heated intra-peritoneal chemotherapy at Waikato.
    Ly NJ; Wu L; Dalen RV; Lolohea S
    N Z Med J; 2017 Jul; 130(1459):33-42. PubMed ID: 28727692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
    Chua TC; Yan TD; Smigielski ME; Zhu KJ; Ng KM; Zhao J; Morris DL
    Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei.
    Bjersand K; Mahteme H; Sundström Poromaa I; Andréasson H; Graf W; Larsson R; Nygren P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S810-6. PubMed ID: 26193962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.